Steven C. Quay

Steven Quay
Steven Quay
Born	Steven C. Quay
Nationality	American
Alma mater	University of Michigan Medical School
Occupation(s)	Author ; scientist ; businessman
Notable work	The Origin of the Virus ; Stay Safe: A Physician's Guide to Survive Coronavirus
Website	drquay.com

Steven C. Quay is an American author, scientist, and businessman. He is the current chief executive officer (CEO) of Atossa Therapeutics.^[1]

Biography

Quay received his education from the University of Michigan Medical School and completed his doctorate in 1975.^[2] Quay worked as a postdoctoral fellow with Nobel Laureate Har Gobind Khorana at MIT.^[3] He has previously worked as a faculty member of Department of Pathology, Stanford University School of Medicine.^[4]

In 2009, Quay founded Atossa Therapeutics, a biopharmaceutical company based in Seattle.^[1] The company is listed on Nasdaq since 2012.^[5]

In September 2021, Quay published a book, The Origin of the Virus: The hidden truths behind the microbe that killed millions of people, along with Angus Dalgleish and Paolo Barnard.^[6] He is also an author of a book named Stay Safe: A Physician's Guide to Survive Coronavirus.^{[citation needed]}

Bibliography

Books

Quay, Steven; Chen, Shu Chih (2016). Nipple Aspirate Fluid Exfoliative Cytopathology and Molecular Biomarkers: Current Role in the Management of Breast Health. Atossa Genetics. ISBN 978-0-9968496-2-3.
Barnard, Paolo; Quay, Steven; Dalgleish, Angus (2021). The Origin of the Virus: The Hidden Truths Behind the Microbe That Killed Millions of People. Clinical Press Limited. ISBN 978-1-85457-106-9.

Publications

Daniels, C. J.; Bole, D. G.; Quay, S. C.; Oxender, D. L. (September 1, 1981). "Role for membrane potential in the secretion of protein into the periplasm of Escherichia coli". Proceedings of the National Academy of Sciences. 78 (9): 5396–5400. Bibcode:1981PNAS...78.5396D. doi:10.1073/pnas.78.9.5396. PMC 348752. PMID 7029533.
Dvorak, H. F.; Quay, S. C.; Orenstein, N. S.; Dvorak, A. M.; Hahn, P.; Bitzer, A. M.; Carvalho, A. C. (May 22, 1981). "Tumor Shedding and Coagulation". Science. 212 (4497): 923–924. Bibcode:1981Sci...212..923D. doi:10.1126/science.7195067. PMID 7195067.
Re, Richard; Fallon, John T.; Dzau, Victor; Quay, Steven C.; Haber, Edgar (January 1982). "Renin synthesis by canine aortic smooth muscle cells in culture". Life Sciences. 30 (1): 99–106. doi:10.1016/0024-3205(82)90641-5. PMID 7033709.
Rocklage, Scott M.; Cacheris, William P.; Quay, Steven C.; Hahn, F. Ekkehardt; Raymond, Kenneth N. (February 1989). "Manganese(II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate). Synthesis and characterization of a paramagnetic chelate for magnetic resonance imaging enhancement". Inorganic Chemistry. 28 (3): 477–485. doi:10.1021/ic00302a019.
Cacheris, William P.; Quay, Steven C.; Rocklage, Scott M. (January 1990). "The relationship between thermodynamics and the toxicity of gadolinium complexes". Magnetic Resonance Imaging. 8 (4): 467–481. doi:10.1016/0730-725x(90)90055-7. PMID 2118207.
Elizondo, G; Fretz, C J; Stark, D D; Rocklage, S M; Quay, S C; Worah, D; Tsang, Y M; Chen, M C; Ferrucci, J T (January 1991). "Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging". Radiology. 178 (1): 73–78. doi:10.1148/radiology.178.1.1898538. PMID 1898538.
Lim, K O; Stark, D D; Leese, P T; Pfefferbaum, A; Rocklage, S M; Quay, S C (January 1991). "Hepatobiliary MR imaging: first human experience with MnDPDP". Radiology. 178 (1): 79–82. doi:10.1148/radiology.178.1.1898539. PMID 1898539.
Costantino, Henry R.; Illum, Lisbeth; Brandt, Gordon; Johnson, Paul H.; Quay, Steven C. (June 2007). "Intranasal delivery: Physicochemical and therapeutic aspects". International Journal of Pharmaceutics. 337 (1–2): 1–24. doi:10.1016/j.ijpharm.2007.03.025. PMID 17475423.

References

^ ^a ^b "Seattle biotech Atossa Therapeutics eyes acquisition of unnamed company".
^ "Steven Quay". June 21, 2016.
^ "Steven Quay".
^ "Letter Seeking International Inquiry Into Origins of the Coronavirus". The New York Times. March 4, 2021.
^ "Sinking stock threatens Atossa's place on the Nasdaq".
^ Sadar, Anthony J. (October 28, 2021). "BOOK REVIEW: 'The Origin of the Virus'". The Washington Times.

[bizjournals-1] "Seattle biotech Atossa Therapeutics eyes acquisition of unnamed company".

[2] "Steven Quay". June 21, 2016.

[3] "Steven Quay".

[4] "Letter Seeking International Inquiry Into Origins of the Coronavirus". The New York Times. March 4, 2021.

[5] "Sinking stock threatens Atossa's place on the Nasdaq".

[6] Sadar, Anthony J. (October 28, 2021). "BOOK REVIEW: 'The Origin of the Virus'". The Washington Times.

[1]

[2]

[3]

[4]

[5]

[6]